[Effect of reducing injection on HFMD in children: a randomized controlled trial].
OBJECTIVE
To study the clinical effects of Reduning Injection on ordinary hand, foot and mouth disease (HFMD) in children.


METHODS
76 children with confirmed diagnosis of HFMD were randomly assigned to 3 groups by the center randomization method, i.e., the Western medicine group (WM, 24 cases, treated with Ribavirin Injection or antibiotics), the Reduning Injection group (RI, 26 cases, treated with Reduning Injection), and the combination group (26 cases, treated with the combination of Reduning injection with Ribavirin Injection or antibiotics). The therapeutic course lasted for 3 to 7 days. A 3-day follow-up study was performed by the end of the treatment. The blood routines, the liver function, the renal function, the fasting blood glucose, the pyretolysis effect initiating time, the time for the body temperature recovery, and the rash subside time were observed in the three groups.


RESULTS
(1) Of 76 patients, 13 dropped out, with the final effective case being 63. Of them, there were 19 cases in the WM group, 22 in the RI group, and 22 in the combination group. (2) Compared with the WM group, the pyretolysis effect initiating time and the time for the body temperature recovery were both significantly shortened in the RI group and the combination group (P<0.05, P<0.01). (3) There was no significant difference in the rash subside time among the three groups (P>0.05). But there was shortening tendency in the RI group and the combination group. (4) One child in the RI group dropped out from this study due to a mild rash, and no adverse drug reaction occurred in the other two groups.


CONCLUSIONS
RI had some advantages in treatment of HFMD such as fasting pyretolysis effect initiating time, shorter time for the body temperature recovery, higher safety. Besides, it also could accelerate the subside of skin rashes to some extent.
Shanghai Public Health Clinical Center, Shanghai 201508. ypmu8888@126.com
Yong-ping
YP
Mu
Xiao-rong
XR
Chen
Ai-jun
AJ
Zhang
D002648:Child; D002675:Child, Preschool; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006232:Hand, Foot and Mouth Disease / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007267:Injections; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use
D004365:Drugs, Chinese Herbal; D012254:Ribavirin